GILEAD SCIENCES, INC.

GILDNasdaq· Biological Products, (No Diagnostic Substances)

Price History

Revenue

$29.4B

▲ 2.4% YoY

Net Income

$8.5B

▲ 1672.9% YoY

EPS

$6.78

▲ 1684.2% YoY

Cash

$7.6B

▼ 24.3% YoY

FY 2025 · As of 2025-12-31

Pro

10-K Year-over-Year Diff

AI-powered analysis of what changed between the last two annual reports — new risks, removed language, strategy shifts.